![Kamel Besseghir](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kamel Besseghir
Directeur/Bestuurslid bij
ONCODESIGN
Profiel
Kamel Besseghir is currently an Independent Director at Oncodesign SA since 2014 and a Director at Oncodesign Precision Medicine SA since 2022.
Formerly, Dr. Besseghir was Chief Executive Officer at Debiopharm International SA from 1995 to 2012.
Other former roles include Principal positions at Serono SA, The State University of New York, and the University of Lausanne.
Actieve functies van Kamel Besseghir
| Bedrijven | Functie | Begin |
|---|---|---|
| ONCODESIGN | Directeur/Bestuurslid | 03-02-2014 |
| ONCODESIGN PRECISION MEDICINE | Directeur/Bestuurslid | 14-09-2022 |
Eerdere bekende functies van Kamel Besseghir
| Bedrijven | Functie | Einde |
|---|---|---|
Debiopharm International SA
 Debiopharm International SA BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops drugs to cure cancer and infectious diseases | President | 01-01-2012 |
Serono SA
 Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs | Corporate Officer/Principal | - |
The State University of New York
 The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
University of Lausanne
 University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
15
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs | Health Technology |
Debiopharm International SA
Debiopharm International SA BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops drugs to cure cancer and infectious diseases | Health Technology |
The State University of New York
The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Lausanne
University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncodesign SA
 Oncodesign SA BiotechnologyHealth Technology Develops preclinical evaluation of novel anticancer therapies | Health Technology |
Oncodesign Precision Medicine SA
 Oncodesign Precision Medicine SA Pharmaceuticals: MajorHealth Technology Discovers and develops new molecules for the health treatments in oncology | Health Technology |
Kies MarketScreener 
